Therapeutic Group: Anti Diabetic Presentation Linatab M 2.5/1000 ER: Each Extended Release tablet contains Linagliptin INN 2.5 mg and Metformin HCl BP 1000 mg. Linatab M 5/1000 ER: Each Extended Release tablet contains Linagliptin INN 5 mg and Metformin HCl BP 1000 mg. Description LINATAB M ER is a combination of 2 oral antihyperglycemic drugs […]
Therapeutic Group: Anti Diabetic Presentation Linatab M 2.5/500: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 500 mg. Linatab M 2.5/850: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 850 mg. Linatab M 2.5/1000: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 1000 mg Description LINATAB M is a […]
Therapeutic Group: Anti Diabetic Presentation Linatab E 5/10: Each tablet contains Linagliptin INN 5 mg and Empagliflozin INN 10 mg. Linatab E 5/25: Each tablet contains Linagliptin INN 5 mg and Empagliflozin INN 25 mg. Description Linatab E is a combination of two oral antihyperglycemic drugs with complimentary mechanism of action to improve glycemic control […]
Therapeutic Group: Anti Diabetic Presentation Linatab : Each tablet contains Linagliptin INN 5 mg. Description Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which exerts its action by slowing the inactivation of incretin hormones. Incretin hormones, including glucagon-like peptide-1(GLP-1) and glucose-dependent Insulinotropic polypeptide (GIP), are released by the intestine throughout the day and levels are increased […]
Therapeutic Group: Gastro Intestinal Disorders Presentation Anacaine HC Cream: Each gram cream contains Lidocaine Hydrochloride BP 30 mg and Hydrocortisone Acetate BP 5 mg. Description Lidocaine inhibits the ionic fluxes required for initiation and conduction of impulses, thereby effecting local anesthetic action. Hydrocortisone acetate provides relief from inflammatory and pruritic manifestations. Indications Anacaine Cream is […]
Therapeutic Group: Respiratory Presentation Purisal 0.31 mg: Each 3 ml ampoule contains Levosalbutamol Hydrochloride INN equivalent to Levosalbutamol 0.31 mg. Purisal 0.63 mg: Each 3 ml ampoule contains Levosalbutamol Hydrochloride INN equivalent to Levosalbutamol 0.63 mg. Purisal 1.25 mg: Each 3 ml ampoule contains Levosalbutamol Hydrochloride INN equivalent to Levosalbutamol 1.25 mg. Description Levosalbutamol Nebuliser […]
Therapeutic Group: Respiratory Presentation Purisal 1: Each tablet contains Levosalbutamol Sulphate INN equivalent to Levosalbutamol 1 mg. Purisal 2: Each tablet contains Levosalbutamol Sulphate INN equivalent to Levosalbutamol 2 mg. Purisal syrup: Each 5 ml syrup contains Levosalbutamol Sulphate INN equivalent to Levosalbutamol 1 mg. Description Levosalbutamol is a single isomer beta-2 agonist that differs […]
Therapeutic Group: Contraceptive Presentation Lyta 28 : Each Lyta 28 package contains 28 pills. Among these 21 pills are white in color and each contains Levonorgestrel BP 0.150 mg & Ethinylestradiol BP 0.030 mg. Each of 7 brown pill contains 75 mg of Ferrous Fumarate BP. Description Lyta 28 contains two active ingredients, Ethinylestradiol and […]
Therapeutic Group: Opthalmic Anti-bacterial Presentation Levoxin TS Eye Drops: Each ml contains Levofloxacin Hemihydrate USP 15.37 mg equivalent to Levofloxacin 15 mg. Description Levofloxacin is a synthetic, broad-spectrum, third generation fluoroquinolone antibacterial agent. It works by the inhibition of bacterial topoisomerase IV and DNA gyrase enzymes required for DNA replication, transcription, repair, and recombination. Indications […]
Therapeutic Group: Anti Bacterial Presentation Levoxin Vet solution: Each 1 ml solution contains Levofloxacin BP 100 mg. Description Levofloxacin is a dependable bactericidal and mycoplasmicidal drug. It is used in prevention and treatment of CRD. Levoxin Vet is an antibiotic of Quinolone group that inhibits the activity of bacterial DNA-gyrase enzyme, causes disruption of bacterial […]